SCHEMBL8629927

SCHEMBL8629927

COc1ccc(C(C)(C)NC(=O)C2CC[C@H]3[C@@H]4CCC5=CC(=O)CC[C@]5(C)[C@@H]4CC[C@]23C)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 8/20 0.61
CYP3A4 P08684 7/20 0.61
ALDH1A1 P00352 6/20 0.61
SMN1; SMN2 Q16637 5/20 0.61
MAPT P10636 5/20 0.61
MAPK1 P28482 4/20 0.61
TSHR P16473 4/20 0.61
NR3C1 P04150 4/20 0.61
PGR P06401 4/20 0.61
SHBG P04278 4/20 0.61
SERPINA6 P08185 4/20 0.61
AR P10275 3/20 0.61
GPBAR1 Q8TDU6 3/20 0.61
SIGMAR1 Q99720 3/20 0.61
CYP2C9 P11712 2/20 0.61
HIF1A Q16665 2/20 0.61
NR1I2 O75469 2/20 0.61
ABCB11 O95342 2/20 0.61
MEN1 O00255 2/20 0.61
KMT2A Q03164 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8629925 1.00 LMNA (0.61) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL8377385 0.90 LMNA (0.64) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL8377389 0.90 LMNA (0.64) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL4245550 0.86 LMNA (0.66) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL4245554 0.86 LMNA (0.66) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL6263252 0.85 LMNA (0.73) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL6263255 0.85 LMNA (0.73) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL8994192 0.82 LMNA (0.68) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL8994186 0.82 LMNA (0.68) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT
SCHEMBL8072118 0.81 LMNA (0.61) LMNACYP3A4ALDH1A1SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5760025-A ADMINISTERING TESTOSTERONE 5A-REDUCTASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1998-06-02 US disclosed
US-5717088-A REACTING WITH A CYANOPHOSPHATE IN THE PRESENCE OF AN ALKALI METAL CYANIDE SANKYO COMPANY, LIMITED (JP) 1998-02-10 US disclosed
US-5698720-A INTERMEDIATES FOR TESTOSTERONE 5-ALPHA-REDUCTASE INHIBITORS SANKYO COMPANY, LIMITED (JP) 1997-12-16 US disclosed
EP-0567271-B1 Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses SANKYO CO (JP) 1997-07-02 EP disclosed
EP-0725074-A2 Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives SANKYO COMPANY LIMITED (JP) 1996-08-07 EP disclosed
US-5536714-A Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses SANKYO COMPANY, LIMITED (JP) 1996-07-16 US disclosed
EP-0567271-A2 Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses SANKYO COMPANY LIMITED (JP) 1993-10-27 EP disclosed